These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23583449)

  • 1. A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway.
    Bridoux L; Etique N; Lambert E; Thevenard J; Sowa ML; Belloy N; Dauchez M; Martiny L; Charpentier E
    FEBS Lett; 2013 May; 587(10):1524-8. PubMed ID: 23583449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival.
    Lambert E; Boudot C; Kadri Z; Soula-Rothhut M; Sowa ML; Mayeux P; Hornebeck W; Haye B; Petitfrere E
    Biochem J; 2003 Jun; 372(Pt 3):767-74. PubMed ID: 12639219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival.
    Lambert E; Bridoux L; Devy J; Dassé E; Sowa ML; Duca L; Hornebeck W; Martiny L; Petitfrère-Charpentier E
    Int J Biochem Cell Biol; 2009 May; 41(5):1102-15. PubMed ID: 19010442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
    Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
    Iqbal MS; Tsuyama N; Obata M; Ishikawa H
    Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Csk-binding protein controls red blood cell development via regulation of Lyn tyrosine kinase activity.
    Plani-Lam JH; Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Singer P; Lam KP; Hibbs ML; Ingley E
    Exp Hematol; 2017 Feb; 46():70-82.e10. PubMed ID: 27751872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.
    Kadri Z; Maouche-Chretien L; Rooke HM; Orkin SH; Romeo PH; Mayeux P; Leboulch P; Chretien S
    Mol Cell Biol; 2005 Sep; 25(17):7412-22. PubMed ID: 16107690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation.
    Adachi T; Stafford S; Sur S; Alam R
    J Immunol; 1999 Jul; 163(2):939-46. PubMed ID: 10395690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells.
    Kummalue T; Inoue T; Miura Y; Narusawa M; Inoue H; Komatsu N; Wanachiwanawin W; Sugiyama D; Tani K
    Exp Hematol; 2015 May; 43(5):414-423.e1. PubMed ID: 25829192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
    Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
    J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells.
    Gamas P; Marchetti S; Puissant A; Grosso S; Jacquel A; Colosetti P; Pasquet JM; Mahon FX; Cassuto JP; Auberger P
    Leukemia; 2009 Aug; 23(8):1500-6. PubMed ID: 19340007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells.
    Bates RC; Edwards NS; Burns GF; Fisher DE
    Cancer Res; 2001 Jul; 61(13):5275-83. PubMed ID: 11431370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.
    ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F
    Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous tissue inhibitor of metalloproteinase-1 promotes endothelial cell survival through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Boulday G; Fitau J; Coupel S; Soulillou JP; Charreau B
    Ann N Y Acad Sci; 2004 Dec; 1030():28-36. PubMed ID: 15659777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.
    Okamoto M; Hayakawa F; Miyata Y; Watamoto K; Emi N; Abe A; Kiyoi H; Towatari M; Naoe T
    Leukemia; 2007 Mar; 21(3):403-10. PubMed ID: 17230226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.